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Objective: Updated knowledge on the validity of self-
reported myocardial infarction (SMI) and self-reported
stroke (SRS) is needed in Norway. Our objective was to
compare questionnaire data and hospital discharge
data from regions with Sami and Norwegian
populations to assess the validity of these outcomes by
ethnicity, sex, age and education.
Design: Validation study using cross-sectional
questionnaire data and hospital discharge data from all
Norwegian somatic hospitals.
Participants and setting: 16 865 men and women
aged 30 and 36–79 years participated in the
Population-based Study on Health and Living
Conditions in Sami and Norwegian Populations
(SAMINOR) 1 Survey in 2003–2004. Information on
SMI and SRS was available from self-administered
questionnaires for 15 005 and 15 088 of these
participants, respectively. We compared this
information with hospital discharge data from 1994
until SAMINOR 1 Survey attendance.
Primary and secondary outcomes: Sensitivity,
specificity, positive predictive value (PPV), negative
predictive value and κ.
Results: The sensitivity and PPV of SMI were 90.1%
and 78.9%, respectively; the PPV increased to 93.1%
when all ischaemic heart disease (IHD) diagnoses were
included. The SMI prevalence estimate was 2.3% and
hospital-based 2.0%. The sensitivity and PPV of SRS
were 81.1% and 64.3%, respectively. The SRS
prevalence estimate was 1.5% and hospitalisation-
based 1.2%. Moderate to no variation was observed in
validity according to ethnicity, sex, age and education.
Conclusions: The sensitivity and PPV of SMI were
high and moderate, respectively; for SRS, both of these
measures were moderate. Our results show that SMI
from the SAMINOR 1 Survey may be used in
aetiological/analytical studies in this population due to
a high IHD-specific PPV. The SAMINOR 1 questionnaire
may also be used to estimate the prevalence of acute
myocardial infarction and acute stroke.
INTRODUCTION
In the absence of registries, epidemiological
studies often use questionnaires to obtain
information on cardiovascular disease (CVD).
Validation studies published within the past
decade and onwards used different instru-
ments and reference standards, and indicated
moderate-to-high sensitivity for self-reported
myocardial infarction (SMI) (78–98%)1–4
and self-reported stroke (SRS) (69–81%),1–5
whereas reported positive predictive values
(PPVs) were lower (SMI: 43–74%;1–4 6 7 SRS:
22–79%1–8).
There have been a few validity and reli-
ability studies of SMI and SRS in Norway,
but recent studies are lacking.8–10 Moreover,
no studies until now have assessed the vali-
dity of these questions in the indigenous
Sami population of Norway. We used ques-
tionnaire data from the SAMINOR 1 Survey,
the first survey of the Population-based
Study on Health and Living Conditions
in Sami and Norwegian Populations,11
and hospital discharge data from the
Cardiovascular Disease in Norway
(CVDNOR) project12 to assess the validity
of SMI and SRS by ethnicity, sex, age and
education.
Strengths and limitations of this study
▪ The overall results are considered representative
for the general population aged 36–79 years in
the SAMINOR 1 region.
▪ Limited selection bias with regard to hospital
discharge records.
▪ Imperfect reference standard.




In 2003–2004, in collaboration with the Norwegian
Institute of Public Health, the Centre for Sami Health
Research conducted the SAMINOR 1 cross-sectional
survey.11 Men and women aged 30 (born 1973–1974)
and 36–79 years (born 1925–1968) residing in selected
regions11 were identified through the National Registry
and invited to participate in the survey, regardless of
their ethnic background (N=27 987). Of those invited,
16 865 (60.3%) agreed to participate. Apart from those
recruited from the municipality of Alta (n=4741), the
population was exclusively rural (ibid.).
The design of the SAMINOR 1 Informed consent was
obtained from all participants. Survey changed during
the data collection. In the original design, which was
used in the predominantly Sami municipalities of Tana,
Nesseby, Karasjok and Kautokeino in Finnmark County,
a two-paged initial questionnaire (Q1) was first sent.
Those who replied and stated that they wanted to take
part in the screening received an invitation to a clinical
examination. The invitation included a three-paged
screening questionnaire—the Q2—which they were
asked to fill in and bring to the examination. The clin-
ical examinations took place in two buses travelling
between the municipalities. This two-stage design led to
a very low attendance at the clinical examination.
Hence, after the first four municipalities, the two-stage
sampling design was dropped. In the rest of the survey,
the Q1 and Q2 were combined into a five-paged ques-
tionnaire which was sent together with the invitation to
the clinical examination. In Finnmark and Troms, the
buses returned after 2 or 3 months, and non-responders
got a second invitation to the screening. In Nordland
and Trøndelag, there was only one screening round and
no reminder. Owing to the original design, not all parti-
cipants provided the Q1 and the Q2. The data collection
is described in detail by Lund et al (ibid.). The question-
naires in Norwegian, Sami and English languages may
be accessed at http://www.saminor.no.
Of the 16 865 participants, 815 did not complete the
Q2—which includes the questions on CVD to be vali-
dated in this paper—and another 87 did not consent to
having their information linked to national registries.
Thus, a total of 15 963 participants were eligible for
inclusion in this validation study.
Separate analyses were conducted for SMI and SRS;
participants were included in both analyses if both
events were reported. Excluded were those with missing
information on SMI (n=676) and/or SRS (n=720).
Participants who did not report their age at the time of
myocardial infarction (n=54) and/or stroke (n=46) were
also excluded. The CVDNOR project does not have hos-
pital discharge data before 1994, and thus participants
with SMI (n=228) and/or SRS (n=109) before this year
were also excluded. The total numbers included in the
final SMI and SRS analyses were 15 005 and 15 088,
respectively.
Questionnaire data
Self-administered questionnaires were used to collect
information on disease, ethnicity and education. SMI
and SRS were measured by the question: Do you have, or
have you had: ‘a myocardial infarction’ and/or ‘a stroke/
brain haemorrhage?’ Response options were ‘yes’ or
‘no’, and participants who answered yes were asked to
report their age at the time of the first event.
Ethnicity was determined by the questions: what lan-
guage(s) do/did you, your parents, and your grandparents use
at home? And what is your, your father’s and your mother’s
ethnic background? The response options for both ques-
tions were ‘Norwegian’, ‘Sami’, ‘Kven’ or ‘other’. The
respondents also reported whether they considered
themselves to be Norwegian, Sami, Kven or other (self-
perceived ethnicity). On all the aforementioned ques-
tions, multiple answers were allowed, and participants
were categorised as Sami if they answered ‘Sami’ to one
or more of the questions above. Respondents who were
born abroad and answered ‘other’ to questions on ethni-
city (n=263) were considered missing values. The
remaining participants were categorised as non-Sami.
Education was assessed by the question: how many years
of schooling/education have you completed? (including all the
years you attended school or have been studying.) Information
on age and sex was collected from the National Registry.
Hospital discharge data
Hospital discharge data were taken from the CVDNOR
project (http://www.cvdnor.no), which is a collaborative
project between the University of Bergen and the
Norwegian Knowledge Centre for the Health Services.
The CVDNOR project retrieved information on all hos-
pital stays with a primary or secondary diagnosis of CVD
or diabetes mellitus (International Classification of
Diseases, Ninth Revision (ICD-9) codes 250, 390–459,
745–747; and ICD-10 codes E10–E14, I00–I99, Q20–
Q28), as well as all related procedures, from the Patient
Administrative Systems (PAS) of all Norwegian somatic
hospitals from 1994 (the year from which all hospitals
adopted an electronic PAS) through 2009.13 The
CVDNOR data contain information on patients’ date
and time of hospital admission and discharge, and up to
21 discharge diagnoses.12
Reference standards
The validity of SMI and SRS was assessed against hospital
discharge data by linking SAMINOR 1 and CVDNOR
data using the unique 11-digit national identification
number assigned to each Norwegian resident. We used
main and secondary hospital discharge diagnosis codes
as reference standards including ICD-9: 410, or ICD-10:
I21 or I22 for acute myocardial infarction (AMI); and
ICD-9: 430, 431, 434 or 436, or ICD-10: I60, I61, I63 or
I64 for cerebral infarction, intracerebral haemorrhage
and subarachnoid haemorrhage (acute stroke). SMI and
SRS were compared with hospital discharge data from
1994 until SAMINOR 1 Survey attendance.
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Statistical analyses
SMI-specific and SRS-specific analyses were performed
using STATA V.14.1 (StataCorp., College Station, Texas,
USA). Sensitivity was the proportion of people hospita-
lised for CVD, who self-reported CVD a/(a+c).
Specificity was calculated as the proportion of non-
hospitalised people who did not report a CVD d/(d+b).
PPV was the proportion of people who reported CVD
who were hospitalised for CVD a/(a+b). Negative pre-
dictive value (NPV) was the proportion of people who
did not report CVD who were not hospitalised for CVD
d/(c+d) (figure 1).
The prevalence of self-reported CVD was calculated
using this formula: (a+b)/(a+b+c+d). The prevalence of
CVD based on hospital data was calculated by the follow-
ing formula: (a+c)/(a+b+c+d).
Since the sensitivity, specificity, NPV and PPV are pro-
portions, statistical methods based on the binomial dis-
tribution are used. The 95% CIs are exact binomial
(Clopper-Pearson intervals) and were computed using
the ‘diagt’ command in STATA. Owing to large groups,
the Pearson’s χ2 test is used for comparisons.14
Cohen’s κ was calculated to determine the agreement
between self-reported information in the SAMINOR 1
questionnaire and hospital discharge data from
CVDNOR. The ‘kapci’ command in STATA was used.
Differences in κ statistics were tested using the following
test statistic:15
Z ¼ jkA  kBjffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
Var(kA)þ Var(kB)
p  N(0; 1):
An alternative categorisation of ethnicity was assessed by
comparing those who reported speaking Sami language
at home with those who did not speak Sami. Potential
selection bias was assessed by checking how many of
those with SMI and SRS and no information on age at
the time of the event were found in the hospital dis-
charge data. We also checked how many of those with
missing self-reported disease status that were found with
a relevant hospital discharge code.
RESULTS
Non-responders tended to be male, younger, non-
married and from Nordland County (table 1).
Poorer response to Q2 was observed in Sami com-
pared with non-Sami; this was due to initial design issues
in predominantly Sami municipalities in Finnmark.11
In the total sample, the sensitivity and PPV for SMI
were 90.1% and 78.9%, respectively; specificity and NPV
were >99.4%. The prevalence of SMI was 2.3%, while the
hospital discharge data showed a prevalence of 2.0%.
The corresponding κ value was 0.84 (table 2). In sensitiv-
ity analyses, only 3 of the 676 participants excluded due
to missing self-reported disease status were found to have
had an AMI in the hospital discharge data, as were 16 of
the 54 participants who failed to report their age at the
time of the event (data not shown).
Owing to the small numbers of SMI and hospital dis-
charge events, precision is lacking and only very large
differences in the sensitivity, PPV with regard to ethni-
city, sex, age, and education would have been statistically
significant in our study. Higher sensitivity (96.6% vs
87.4%) was observed in those aged ≤59 years compared
with those aged ≥60 years (p<0.05). Small but statistic-
ally significant differences (p<0.05) were found for sex,
age and education in terms of specificity and NPV which
were consistently ≥99.0%. No significant ethnic variation
in the validity of SMI was observed (table 2).
In the total sample, the sensitivity and PPV for SRS
were 81.1% and 64.3%, respectively; specificity and NPV
were >99.4. The prevalence of SRS was 1.5%, while the
hospital discharge data gave a prevalence of 1.2%. The
κ was 0.71 (table 3). Sensitivity analyses showed that only
4 of the 720 participants excluded due to missing SRS
status had an acute stroke event as of the hospital dis-
charge data (data not shown). Furthermore, only 10 of
the 46 participants who failed to report their age at
disease onset had a relevant discharge code (data not
shown).
As with SMI, statistical power and precision are low
when comparing the sensitivity, PPV and κ between cat-
egories of the selected demographic variables. A sub-
stantially higher PPV (81.8% vs 59.1%) was found
among participants with ≥12 years compared with 0–11
years of education (p<0.05). Small but statistically signifi-
cant (p<0.05) differences were observed for age and
education in terms of specificity and NPV, as well as for
sex in terms of NPV; all were >99.1. Statistically signifi-
cant (p<0.05) stronger κ coefficients were observed in
participants aged 30–59 years compared with those aged
60–79 years (0.76 vs 0.68), and for education ≥12 years
compared with 0–11 years (0.83 vs 0.67) (table 3).
Of the 346 SMIs, 73 could not be verified in the hospital
discharge data. However, 43 of these (12% of all SMIs)
had a discharge code of angina pectoris (ICD-9: 411, 413;
ICD-10: I20), and 6 (2% of all SMIs) had a discharge code
of ischaemic heart disease (IHD) (ICD-9: 412, 414; ICD
19: I24–I25) other than AMI and angina pectoris
(table 4). This gave an IHD-specific PPV of 93.1%.
Among the 221 participants with SRS, we were unable
to find a relevant stroke discharge code for 79; among
these, we found that 7 (3% of all SRSs) and 12 (5% of
Figure 1 Calculation of sensitivity, specificity, PPV, NPV and
prevalence. CVD, cardiovascular disease; NPV, negative
predictive value; PPV, positive predictive value.
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all SRSs) had discharge codes referring to a transient
ischaemic attack (TIA) (ICD-9: 435.9; ICD-10: G45.9) or
other cerebrovascular diseases (ICD-9: 432–433, 435,
437–438; ICD-10: I65–I69), respectively (table 4). None
had a code referring to intracranial injury (850–854,
S06) or amaurosis fugax (362.34, G45.3) (data not
shown).
The alternative definition of ethnicity did not affect
results.
DISCUSSION
The sensitivity (90.1%) and PPV (78.9%) of SMI were
high and moderate, respectively; the PPV increased to
93.1% when all IHD diagnoses were considered. For
SRS, both of these measures were moderate (81.1% and
64.3%). The self-reported prevalence estimates were
almost identical to those based on hospital discharge
data for both SMI and SRS. Moderate to no variation
was observed in validity according to ethnicity, sex, age
and education.
The validity of a questionnaire may vary across popula-
tions, time periods and social circumstances.16
Furthermore, when comparing results from validation
studies, it is important to consider the reference stand-
ard used, and which information was obtained from
questionnaires. Indeed, these variables vary widely
between studies, which may contribute to the disparity
that has been observed in this field of research.1
Nevertheless, we have identified some common findings
between our study and recent studies based on
population-based survey data that included both sexes
and middle-aged and older participants.1–8
A typical AMI is easily recalled, as it usually involves
severe pain and hospitalisation, which enhance the valid-
ity of SMI.3 Only a few studies have provided κ values for
SMI, but the agreement they1 3 4 reported was lower
than that found in our study (κ=0.84). However, κ mea-
surements may be affected by marginal totals and
disease prevalence.17 18 While the corresponding sensi-
tivity estimate for SMI in our study was high (90.1%),
which is in accordance with recent literature,1–4 our PPV
Table 1 Characteristics of the invited cohort in the SAMINOR 1 Survey (2003–2004) aged 30 and 36–79 years, total
participants,* respondents to the Q2† and included subsamples
Invited (%) Total participants (%)* Completed the Q2† SMI (%)‡ SRS (%)§
Number 27 987 16 865 16 050 15 005 15 088
Attendance (%) 100 60.3 57.4 53.6 53.9
Sex
Women 13 446 (48) 8755 (52) 8389 (52) 7872 (52) 7867 (52)
Men 14 541 (52) 8110 (48) 7661 (48) 7133 (48) 7221 (48)
Age (years)
30–59 19 323 (69) 11 430 (68) 10 878 (68) 10 381 (69) 10 361 (69)
60–79 8664 (31) 5435 (32) 5172 (32) 4624 (31) 4727 (31)
County
Trøndelag 1526 (5) 994 (6) 994 (6) 957 (6) 955 (6)
Nordland 2666 (10) 1223 (7) 1223 (8) 1146 (8) 1151 (8)
Troms 6725 (24) 3998 (24) 3996 (25) 3544 (24) 3562 (24)
Finnmark 17 070 (61) 10 650 (63) 9837 (61) 9358 (62) 9420 (62)
Marital status
Single 7057 (25) 3415 (20) 3159 (20) 2981 (20) 2980 (20)
Married 15 394 (55) 10 354 (62) 9953 (62) 9327 (62) 9388 (62)
Widow(er) 1826 (7) 1066 (6) 1015 (6) 905 (6) 924 (6)
Divorced 3071 (11) 1712 (10) 1624 (10) 1506 (10) 1510 (10)
Separated 638 (2) 318 (2) 299 (2) 286 (2) 286 (2)
Ethnicity
Non-Sami 10 390 (62) 10 222 (64) 9546 (64) 9618 (64)
Sami 5915 (35) 5297 (33) 4963 (33) 4982 (33)
Missing/born abroad 560 (3) 531 (3) 496 (3) 488 (3)
Education
0–11 years 8 635 (54) 7959 (53) 8034 (53)
≥12 years 6424 (40) 6182 (41) 6181 (41)
Missing 991 (6) 864 (6) 873 (6)
*Participants who consented to medical research, and completed at least one questionnaire or attended the clinical examination.
†Participants who completed the screening questionnaire (Q2).
‡Participants who consented to having their information linked to national registries, and responded to the question: Do you have, or have you
had: ‘a myocardial infarction?’ (SMI).
§Participants who consented to having their information linked to national registries, and responded to the question: Do you have, or have you
had: ‘a stroke/brain haemorrhage?’ (SRS).
SMI, self-reported myocardial infarction; SRS, self-reported stroke.
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Table 2 Validity of self-reported myocardial infarction in participants aged 30 and 36–79 years by ethnicity, sex, age and education. The SAMINOR 1 Survey (2003–2004)
and the CVDNOR project, n=15 005.
PAS† Sensitivity Specificity PPV NPV κ
Self-reported myocardial
infarction Yes No (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
Total
Yes 273 73 90.1% 99.5% 78.9% 99.8% 0.84
No 30 14 629 (86.2 to 93.2) (99.4 to 99.6) (74.2 to 83.1) (99.7 to 99.9) (0.81 to 0.87)
Ethnicity‡
Sami Yes 91 28 90.1% 99.4% 76.5% 99.8% 0.82
No 10 4834 (82.5 to 95.1) (99.2 to 99.6) (67.8 to 83.8) (99.6 to 99.9) (0.77 to 0.88)
Non-Sami§ Yes 174 44 91.1% 99.5% 79.8% 99.8% 0.85
No 17 9311 (86.1 to 94.7) (99.4 to 99.7) (73.9 to 84.9) (99.7 to 99.9) (0.81 to 0.89)
Sex
Women Yes 73 19 89.0% 99.8%* 79.3% 99.9%* 0.84
No 9 7771 (80.2 to 94.9) (99.6 to 99.9) (69.6 to 87.1) (99.8 to 99.9) (0.78 to 0.90)
Men Yes 200 54 90.5% 99.2% 78.7% 99.7% 0.84
No 21 6858 (85.8 to 94.0) (99.0 to 99.4) (73.2 to 83.6) (99.5 to 99.8) (0.80 to 0.87)
Age
30–59 years Yes 85 28 96.6%* 99.7%* 75.2% 100%* 0.84
No 3 10 265 (90.4 to 99.3) (99.6 to 99.8) (66.2 to 82.9) (99.9 to 100) (0.79 to 0.90)
60–79 years Yes 188 45 87.4% 99.0% 80.7% 99.4% 0.83
No 27 4364 (82.3 to 91.6) (98.6 to 99.3) (75.0 to 85.6) (99.1 to 99.6) (0.79 to 0.87)
Education¶
0–11 years Yes 195 49 87.8% 99.4%* 79.9% 99.7%* 0.83
No 27 7688 (82.8 to 91.8) (99.2 to 99.5) (74.3 to 84.8) (99.5 to 99.8) (0.80 to 0.87)
≥12 years Yes 49 17 94.2% 99.7% 74.2% 100 0.83
No 3 6113 (84.1 to 98.8) (99.6 to 99.8) (62.0 to 84.2) (99.9 to 100) (0.76 to 0.90)
*p<0.05, Column-specific Pearson’s χ2 test for difference between the two categories of each variable.
†Includes primary or secondary discharge diagnoses of ICD-9: 410; ICD-10: I21, I22 from the PAS of all Norwegian somatic hospitals from 1994 through SAMINOR 1 attendance.
‡Smaller n due to missing values: n=496.
§No Sami identity marks reported.
¶Smaller n due to missing values: n=864.
CVDNOR, Cardiovascular Disease in Norway; ICD-9, International Classification of Diseases, Ninth Revision; ICD-10, International Classification of Diseases, Tenth Revision; NPV, negative



















Table 3 Validity of self-reported stroke in participants aged 30 and 36–79 years by ethnicity, sex, age and education. The SAMINOR 1 Survey (2003–2004) and the
CVDNOR project, n=15 088.
PAS† Sensitivity Specificity PPV NPV κ
Self-reported stroke Yes No (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
Total
Yes 142 79 81.1% 99.5% 64.3% 99.8% 0.71
No 33 14 834 (74.5 to 86.6) (99.3 to 99.6) (57.6 to 70.6) (99.7 to 99.9) (0.66 to 0.76)
Ethnicity‡
Sami Yes 50 25 79.4% 99.5% 66.7% 99.7% 0.72
No 13 4894 (67.3 to 88.5) (99.3 to 99.7) (54.8 to 77.1) (99.5 to 99.9) (0.64 to 0.81)
Non-Sami§ Yes 90 52 84.1% 99.5% 63.4% 99.8% 0.72
No 17 9459 (75.8 to 90.5) (99.3 to 99.6) (54.9 to 71.3) (99.7 to 99.9) (0.66 to 0.78)
Sex
Women Yes 58 38 84.1% 99.5% 60.4% 99.9%* 0.70
No 11 7760 (73.3 to 91.8) (99.3 to 99.7) (49.9 to 70.3) (99.7 to 99.9) (0.62 to 0.78)
Men Yes 84 41 79.2% 99.4% 67.2% 99.7% 0.72
No 22 7074 (70.3 to 86.5) (99.2 to 99.6) (58.2 to 75.3) (99.5 to 99.8) (0.66 to 0.79)
Age
30–59 years Yes 54 25 87.1% 99.8%* 68.4% 99.9%* 0.76**
No 8 10 274 (76.1 to 94.3) (99.6 to 99.8) (56.9 to 78.4) (99.8 to 100) (0.69 to 0.84)
60–79 years Yes 88 54 77.9% 98.8% 62.0% 99.5% 0.68
No 25 4560 (69.1 to 85.1) (98.5 to 99.1) (53.5 to 70.0) (99.2 to 99.6) (0.62 to 0.75)
Education¶
0–11 years Yes 91 63 77.8% 99.2%* 59.1%* 99.7%* 0.67**
No 26 7854 (69.2 to 84.9) (99.0 to 99.4) (50.9 to 66.9) (99.5 to 99.8) (0.60 to 0.73)
≥12 years Yes 27 6 84.4% 99.9% 81.8% 99.9% 0.83
No 5 6143 (67.2 to 94.7) (99.8 to 100) (64.5 to 93.0) (99.8 to 100) (0.73 to 0.93)
*p<0.05, column-specific Pearson’s χ2 test for difference between the two categories of each variable. **p<0.05, test for difference in κ statistics between the two categories of each variable:
Z ¼ jkA  kBjffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
Var(kA)þ Var(kB)
p  N(0; 1).
†Includes primary or secondary discharge diagnoses of ICD-9: 430, 431, 434, 436; ICD-10: I60, I61, I63, I64 from the PAS of all Norwegian somatic hospitals from 1994 through SAMINOR 1
attendance.
‡Smaller n due to missing values: n=488.
§No Sami identity marks reported.
¶Smaller n due to missing values: n=873.
CVDNOR, Cardiovascular Disease in Norway; ICD-9, International Classification of Diseases, Ninth Revision; ICD-10, International Classification of Diseases, Tenth Revision; NPV, negative



















of 78.9% was higher than what has been reported previ-
ously.1–4 6 7 The high specificities and NPVs in our total
sample (>99.4%) are also in line with earlier studies.
Twelve per cent of all participants with SMI had a dis-
charge code indicating angina pectoris, not AMI.
Norwegian hospitals adopted the use of troponin during
1999–2001.19 The troponin method is more sensitive
than earlier methods and have probably increased the
rates of AMI as diagnosis on the cost of angina pectoris.
Some patients may have been told that an acute heart
attack diagnosed as angina during 1994–2001 could be
an AMI according to new diagnostics, thus leading to a
subsequent false-positive SMI. In an Australian study,
Barr et al6 found that 18% of all SMIs were in fact
unstable angina as per World Health Organization
(WHO)/Multinational MONItoring of trends and deter-
minants in CArdiovascular disease (MONICA) criteria.20
In most instances, IHDs share an underlying patho-
physiological condition (atherosclerosis); hence, one
may conclude that the high IHD-specific PPV of 93.1%
in our study justifies the use of the SAMINOR 1 ques-
tionnaire in aetiological/analytical studies of AMI in this
population. This study also showed that the SAMINOR 1
questionnaire is valid in terms of estimating the preva-
lence of AMI.
Similar to AMI, a stroke often has an abrupt onset and
causes impairment leading to hospitalisation. The sensi-
tivity (81.1%), PPV (64.3%) and κ (0.71) estimates for
SRS in this study were in the higher range of what has
been previously found.1–8 Three and five per cent of
those reporting a stroke did not have a hospitalisation
for acute stroke, but for TIA or other cerebrovascular
diseases, respectively. Engstad et al8 and Machón et al1
found that about 6% of SRSs’ were in reality TIAs. We
observed a large proportion of false-positive self-reports.
Given this and the fact that ischaemic stroke and haemor-
rhagic strokes have different risk factor patterns,21 one
may conclude that the use of SRS is inappropriate in
aetiological/analytical studies. However, owing to the low
false-negative rate, the variable is valid in terms of estimat-
ing the prevalence of acute stroke in this population.
Overall, no significant ethnic differences were
observed with regard to the validity of SMI or SRS. We
found no papers addressing the validity of
questionnaire-assessed CVD in indigenous peoples.
Machón et al1 found lower sensitivity and higher PPV
in men compared with women with regard to both SMI
and SRS. Lower PPV for SMI in women was observed by
Yamagishi et al.2 Engstad et al8 found higher PPV for
SRS in men than in women. We found no evidence of
this. As mentioned earlier, however, owing to the small
numbers of SMI, SRS and hospital discharge events,
only very large differences would have been statistically
significant in our study. Age ≤60 years was associated
with increased sensitivity of SMI and of SRS in our
study. Engstad et al8 found a borderline significantly
higher PPV for SRS (83% vs 73%) in those aged
>60 years. In the study by Yamagishi,2 age <65 years
compared with age ≥65 years was associated with
increased validity for SMI and SRS. Poorer validity in
older age may be due to age-related memory loss. For
SRS, stroke-induced cognitive impairment may also be a
plausible explanation.
Older age in this population was related to fewer years
of education, as education opportunities in rural Norway
developed gradually after World War II. Increased
schooling may be related to the ability to understand
health-related information22 and may potentially influ-
ence the ability to correctly report the presence or
absence of ill health. SRS rendered higher PPV among
those with ≥12 years of education. Few studies have
examined the influence of education on the validity of
SMI and SRS. Engstad et al8 found that higher education
did not influence the PPV of SRS in the Tromsø study.
Similar educational attainment in Sami and non-Sami23
may be a possible explanation for some of the ethnic
homogeneity observed in this study.
Strengths
The relatively large study sample enabled an in-depth
analysis of the validity of SMI and SRS. CVDNOR covers
the whole population of Norway; thus, there is limited
selection bias with regard to hospital discharge records
in this study. The total results are considered representa-
tive for the general population aged 36–79 years in the
SAMINOR 1 region (see below).
Table 4 Hospital discharge codes in those with false-positive self-reported myocardial infarction and stroke. The SAMINOR
1 Survey (2003–2004) and the CVDNOR project.
Self-reported and registered events (ICD-9; ICD-10) n
Myocardial infarction 73
Angina pectoris (411, 413; I20) 43
Other ischaemic heart diseases (412, 414; I24–I25) 6
An ischaemic heart diseases event 24
Stroke/brain haemorrhage 79
Transient ischaemic attack (435.9; G45.9) 7
Other cerebrovascular diseases (432–433, 435, 437–438; I65–I69) 12
Not a cerebrovascular disease event 60
CVDNOR, Cardiovascular Disease in Norway; ICD-9, International Classification of Diseases, Ninth Revision; ICD-10, International
Classification of Diseases, Tenth Revision.
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Limitations
Overall, non-responders in SAMINOR 1 were more
likely to be males, of younger age (especially 30 years),11
from Nordland County and single (table 1). This is in
line with previous population-based studies in Norway
having shown poorer participation in the ill, in men and
in younger age groups.24 The results specific to sex and
age in this study are thus somewhat uncertain; we
believe, however, that the differences in response rates
are not big enough as to affect total results.
Furthermore, owing to initial design issues, poorer
response to the Q2 in certain municipalities dominated
by people of Sami ethnicity was observed. However,
response rates were not too different; this has thus prob-
ably not affected the results specific to ethnicity and
hence the overall results.
Some AMIs may have occurred without symptoms,
leading to false-negative self-reporting and an absence
of a registered AMI in the hospital discharge data.
Furthermore, an AMI could be diagnosed without
leading to hospitalisation, resulting in a true-positive
SMI not being confirmed in hospital discharge data.
However, we believe that this is not a major problem in
this study, as hospitalisation among patients with AMI
has been common for decades in Norway. In a forth-
coming Norwegian study, one found a PPV of ∼95% for
hospital admissions with a main or secondary diagnosis
of AMI (ICD-10: I21 and I22) when compared with
adjudication of medical records (Ragna Elise Støre
Govatsmark, personal communication, 2016). This sug-
gests that our reference standard is more or less correct.
A recent Norwegian study reported a PPV of 79.7%
for hospital admissions with a main or secondary diagno-
sis of acute stroke (ICD-10: I61, I63, and I64) when com-
pared with adjudication of medical records; 65% of the
false-positives were defined as previous strokes, rehabili-
tations after stroke or old strokes not previously diag-
nosed.25 In the past, however, patients with ischaemic
stroke were not consistently admitted to hospitals for
exact diagnosis and specific treatment, although this
practice has become more standard in the past
decade.26 Thus, stroke may have been diagnosed in
primary care alone, particularly during the first decade
of the CVDNOR database (1994–2004). In a community
study from Norway in the late 1990s, Ellekjær et al27
found that 41 of the 430 patients with incident stroke
were not hospitalised. They also found that the sensitiv-
ity and PPV of hospital discharge ICD-9 codes 430, 431,
434 and 436 were 81% and 68%, respectively, when com-
pared with a register also including non-hospitalised
cases. Consequently, the validity of the SRS in this study
may hence be either overestimated or underestimated;
non-hospitalised strokes are likely to be milder than hos-
pitalised cases. We may thus assume that by missing
potentially milder stroke cases from the reference stand-
ard in our study, we could be overestimating the sensitiv-
ity of SRS; milder cases might be reported less accurately
by participants, either because they are less likely to be
recalled, or because they are more easily confused with
TIA. If milder cases, however, are reported correctly, the
PPV of SRS may be underestimated. This suggests that
hospital discharge data is an imperfect reference stand-
ard with regard to SRS in our study.
Participants with SMI (n=54) and/or SRS (n=46) who
did not specify their age at disease onset were excluded
from the analyses, which may have introduced selection
bias. However, if people failed to recall their age at
disease onset, it is likely that in reality the event dates
back years or even decades. Cases before 1994 could not
be validated using CVDNOR data. Nonetheless, we found
that 16 of those with SMI, and 10 of those with SRS who
did not specify their age at disease onset, had been hospi-
talised with an AMI or an acute stroke during the study
period. If they had been included in the analyses as true
positives, the sensitivity and PPV would be even higher.
CONCLUSION
The sensitivity and PPV of SMI were high and moderate,
respectively; for SRS, both of these measures were mod-
erate. Our results show that SMI from the SAMINOR 1
Survey may be used in aetiological/analytical studies in
this population due to a high IHD-specific PPV. The
SAMINOR 1 questionnaire may also be used to estimate
the prevalence of AMI and acute stroke.
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